Pierre Belichard, Enterome CEO
Nestlé puts down $40M, kicks off deal with gut microbiome specialist to fight food allergies
French company Enterome, which works with the microbiome, has scored $40 million in a wide-ranging deal with its long-time Swiss investor Nestlé Health Science to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
